Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SPARROW trial of standard versus pre-emptive antibiotics after Whipple procedure
NL-OMON56173Recruiting
- Sponsor
- Leiden University Medical Center
- Start
- Mar 2023
- Modality
- Small Molecules, Implantable Devices → Device-based Delivery → Drug Delivery Systems, Transdermal Patches → Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
Randomised, open-label trial of cefazolin, metronidazole, gentamicin and cefuroxime in pancreatic cancer (PC) (2 arms), sponsored by Leiden University Medical Center. Started Mar 2023; status: recruiting.
02
Drugs
cefazolinmetronidazolegentamicincefuroxime
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on NL-OMON56173.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON56173.